- Home
- CNXC vs OGN Comparison
CNXC vs OGN Comparison
Compare CNXC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNXC
- OGN
- Stock Information
- Founded
- CNXC 1991
- OGN 1923
- Country
- CNXC United States
- OGN United States
- Employees
- CNXC N/A
- OGN N/A
- Industry
- CNXC Computer Software: Prepackaged Software
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- CNXC Technology
- OGN Health Care
- Exchange
- CNXC Nasdaq
- OGN Nasdaq
- Market Cap
- CNXC 3.0B
- OGN 2.5B
- IPO Year
- CNXC N/A
- OGN N/A
- Fundamental
- Price
- CNXC $52.07
- OGN $9.44
- Analyst Decision
- CNXC Buy
- OGN Hold
- Analyst Count
- CNXC 4
- OGN 4
- Target Price
- CNXC $68.75
- OGN $18.00
- AVG Volume (30 Days)
- CNXC 644.6K
- OGN 4.8M
- Earning Date
- CNXC 09-24-2025
- OGN 08-05-2025
- Dividend Yield
- CNXC 2.55%
- OGN 0.85%
- EPS Growth
- CNXC N/A
- OGN N/A
- EPS
- CNXC 3.65
- OGN 2.69
- Revenue
- CNXC $9,625,029,000.00
- OGN $6,281,000,000.00
- Revenue This Year
- CNXC $3.66
- OGN N/A
- Revenue Next Year
- CNXC $3.20
- OGN $1.02
- P/E Ratio
- CNXC $14.31
- OGN $3.51
- Revenue Growth
- CNXC 11.31
- OGN N/A
- 52 Week Low
- CNXC $36.28
- OGN $8.01
- 52 Week High
- CNXC $77.00
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- CNXC 53.22
- OGN 49.73
- Support Level
- CNXC $48.39
- OGN $9.15
- Resistance Level
- CNXC $50.73
- OGN $9.48
- Average True Range (ATR)
- CNXC 1.98
- OGN 0.45
- MACD
- CNXC 0.55
- OGN 0.03
- Stochastic Oscillator
- CNXC 92.48
- OGN 56.14
About CNXC Concentrix Corporation
Concentrix Corp is a technology enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Frances and Others. Maximum revenue is from Technology and consumer electronics industry and geographically from Philippines.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.